Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Biochemical Pharmacology|November 16, 2018
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistanceNing Ji, Yuqi Yang, Zi-Ning Lei, et al.
Frontiers in Cell and Developmental Biology|April 8, 2021
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft ModelZi-Ning Lei, Qiu-Xu Teng, Pranav Gupta, et al.
Cancers|September 9, 2020
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug ResistanceYunali V Ashar, Jingchun Zhou, Pranav Gupta, et al.
Frontiers in Pharmacology|November 15, 2018
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC TransportersNing Ji, Yuqi Yang, Chao-Yun Cai, et al.
Cancer Letters|December 15, 2019
Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemiaPranav Gupta, Guan-Nan Zhang, Anna Maria Barbuti, et al.
Cancers|February 27, 2020
Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In VivoGuan-Nan Zhang, Pranav Gupta, Ming Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 28, 2018
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer CellsPranav Gupta, Yun-Kai Zhang, Xiao-Yu Zhang, et al.
Molecules (Basel, Switzerland)|December 6, 2019
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 ExpressionDan Liao, Wei Zhang, Pranav Gupta, et al.
Frontiers in Oncology|May 21, 2019
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Chao-Yun Cai, Hai-Ling Gao, et al.
Oncotarget|April 21, 2017
Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cellsYan Wen, Rui-Qiang Zhao, Yun-Kai Zhang, et al.
Pageof 15